Weekly Trade Suggestions — 2026-10-11
The major averages finished the week of 2026-10-09 mixed but resilient at the index level.
Weekly Trade Suggestions — 2026-10-11
Date: 2026-10-11 Coverage: General market — not personalized (week ending 2026-10-09)
1. Market Pulse
The major averages finished the week of 2026-10-09 mixed but resilient at the index level. The S&P 500 gained 0.5% to 7,811.54 (up 13.9% YTD), the Dow Jones Industrial added 0.8% to 51,654.95 (up 6.8% YTD), while the Nasdaq Composite slipped 0.4% to 27,366.17 despite still leading on the year at 17.8%. Volatility was notably subdued: the CBOE Volatility Index closed at 14.84, down 4.4% on the week and only 2.3% higher year-to-date. A sub-15 VIX alongside a soft Nasdaq tells you the market is not pricing broad risk — it is pricing rotation beneath a calm surface.
The rate backdrop explains much of that rotation. The Treasury curve on 2026-10-09 ran 4.25% at three months, 4.32% at six months, 4.80% at two years, 5.24% at ten years, and 5.60% at thirty years. The 10-year at 5.24% and the 30-year at 5.60% represent a positively sloped, long-end-heavy curve — the curve is no longer inverted (10s minus 2s at roughly +44bp), but the term premium is steep. For equity investors this means the discount rate on long-duration cash flows remains high, and the income available from short paper (4.13%–4.32% out to six months) is a genuine competitor to equities.
Sector tone confirmed a defensive tilt. Utilities (+2.78%) and Healthcare (+2.10%) led by a wide margin, followed by Consumer Cyclical (+1.26%), Real Estate (+0.95%), and Basic Materials (+0.93%). Lagging were Industrials (-0.88%), Technology (-0.63%), and Communication Services (-0.55%), with Energy essentially flat (-0.19%). That is the classic profile of money leaving high-multiple growth and moving toward cash-generative, rate-insensitive earnings. The week's headlines leaned thematic rather than macro: Street Calls of the Week, a possible take-private in European towers (INWIT), Starlink's India push ahead of a record Jio IPO, HSBC flagging eight emerging markets for 2027, and foreign investors retreating from South Korean equities as the AI trade loses momentum. Notably, one headline asked whether a 30-year Treasury belongs in a nest egg — a fair question with the long bond yielding 5.60% and BND down 5.2% YTD.
2. Top Dividend Stocks
| Ticker | Company | Yield % | P/E | YTD % | Payout | Why Now |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 2.0 | 30.3 | 26.1 | n/a | Healthcare leadership (+2.10% sector) plus a 1.9 - Buy rating; fwd P/E 21.5 |
| PG | Procter & Gamble Company (The) | 2.8 | 22.8 | 6.7 | n/a | Defensive staple, steady 2.1 - Buy, added 3.6% on the week |
| KO | Coca-Cola Company (The) | 2.4 | 26.4 | 27.4 | n/a | 1.8 - Buy, resilient demand profile, 27.4% YTD momentum |
| ABBV | AbbVie Inc. | 2.5 | 78.1 | 20.6 | n/a | Fwd P/E of 17 vs trailing 78.1 signals earnings inflection; 1.7 - Buy |
| XOM | ExxonMobil Holdings Corporation | 2.4 | 21.7 | 37.7 | n/a | Energy lagged the tape (-0.19%), fwd P/E 14.7, 2.4 - Buy |
| MCD | McDonald's Corporation | 3.1 | 19.1 | -22.4 | n/a | Cheapest consumer name here at 19.1 P/E; 2.1 - Buy, YTD weakness is the entry |
| VZ | Verizon Communications Inc. | 6.1 | 10.8 | 2.8 | n/a | Highest yield in the bucket at 6.1%, fwd P/E 7.9; fell 9.2% on the week |
The dividend theme is being pulled in two directions. On one hand, defensive staples and healthcare are working — PG, JNJ, KO and ABBV all rose 1.8%–4.0% last week as capital rotated out of Technology and Industrials. On the other, the single highest yielder in the bucket, VZ at 6.1% with a 7.9 forward P/E, dropped 9.2%, a reminder that a fat yield without price stability is a trap, not income. The presence of PEP (4.5% yield, 15.8 P/E, -11.4% YTD) and MCD (3.1% yield, -22.4% YTD) shows the same tension: consumer staples have de-rated hard even as the sector grinds higher. For income-oriented investors, the practical read is to favor names where the yield is paired with a constructive rating and a reasonable forward multiple — ABBV, XOM, CVX, MCD — and to size the deep-value, high-yield outliers (VZ) as speculative rather than core. With the 10-year Treasury at 5.24%, any equity yield below that only makes sense if the dividend grows; that is where the 'n/a' payout and 5-year growth fields would matter most, and they are unavailable in current feeds.
3. Top Growth Stocks
| Ticker | Company | YTD % | Fwd P/E | Analyst Rating | Rev Growth | Catalyst |
|---|---|---|---|---|---|---|
| NVDA | NVIDIA Corporation | 21.4 | 14.4 | 1.3 - Strong Buy | n/a | Fwd P/E of 14.4 is the lowest in the large-cap growth bucket despite a 5536.4B cap; weekly dip of 4.0% |
| MSFT | Microsoft Corporation | 13.1 | 22.6 | 1.3 - Strong Buy | n/a | Steady compounder, +1.9% on a week when Tech fell 0.63%; cloud/AI monetization |
| AMZN | Amazon.com, Inc. | 15.9 | 25.1 | 1.3 - Strong Buy | n/a | Strongest weekly move in the group at +4.4%; consumer cyclical sector led +1.26% |
| GOOGL | Alphabet Inc. | 11.6 | 23.1 | 1.4 - Strong Buy | n/a | Trailing P/E of 17.6 vs 23.1 forward; advertising plus AI infrastructure |
| META | Meta Platforms, Inc. | 10.5 | 20.8 | 1.4 - Strong Buy | n/a | Below-market 20.8 fwd P/E; -3.1% weekly pullback creates an entry |
| AVGO | Broadcom Inc. | 4.0 | 18.6 | 1.3 - Strong Buy | n/a | Fwd P/E 18.6 vs trailing 46.2; custom silicon and networking demand |
| LLY | Eli Lilly and Company | 9.2 | 24.8 | 1.6 - Buy | n/a | Healthcare sector up 2.10%; GLP-1 franchise; +3.2% on the week |
Growth is no longer a monolith. The leaders on price are AMD (+172.1% YTD, trading at a 155.1 trailing and 38.7 forward P/E) and PANW (+133.5% YTD at a 1047 trailing P/E), but both are priced for perfection and neither is a comfortable core holding at those multiples. The more interesting setup is the mega-cap complex, where forward multiples have compressed meaningfully: NVDA at 14.4 forward, AVGO at 18.6, META at 20.8, GOOGL at 23.1, MSFT at 22.6. Every one of them carries a Strong Buy consensus of 1.3–1.4. That combination — high-conviction ratings with single-digit-to-low-20s forward multiples — is unusual for growth exposure and reflects the market's willingness to pay for near-term earnings but not to extrapolate. Note that technology was the second-worst sector last week at -0.63% and Communication Services was third-worst at -0.55%, so this is a buy-the-dip framework rather than a momentum one. Revenue growth figures are 'n/a' across the bucket, so position sizing should lean on the rating and multiple rather than a growth-rate screen. AMD, PANW and NOW are the names where valuation risk is highest.
4. Top ETFs
| Ticker | Name | YTD % | Yield % | AUM ($B) | ER | Best For |
|---|---|---|---|---|---|---|
| VOO | Vanguard S&P 500 ETF | 13.9 | 0.8 | 1729.3 | n/a | Core U.S. large-cap beta at a 25.2 P/E; matches S&P 500 YTD exactly |
| QQQ | Invesco QQQ Trust, Series 1 | 22.5 | 0.2 | 498.9 | n/a | Growth/tech tilt; 22.5% YTD but -0.7% on the week |
| SCHG | Schwab U.S. Large-Cap Growth ETF | 13.0 | n/a | 63.9 | n/a | Lower-cost growth sleeve; 30.3 P/E, +0.1% weekly |
| SCHD | Schwab US Dividend Equity ETF | 19.1 | n/a | 107.9 | n/a | Quality dividend core; 18.2 P/E, +1.0% on the week |
| VYM | Vanguard High Dividend Yield ETF | 9.7 | n/a | 95.8 | n/a | Broad high-yield exposure at 19.9 P/E; +1.1% weekly |
| JEPI | JPMorgan Equity Premium Income | -1.0 | n/a | 45.3 | n/a | Defensive/low-volatility income, 25.2 P/E |
| BND | Vanguard Total Bond Market ETF | -5.2 | n/a | 389.1 | n/a | Core bond duration; -5.2% YTD is the caution flag at a 5.24% 10-year |
Flows are being driven by a valuation-vs-income tug of war. QQQ still leads on 2026 performance at 22.5%, but it lost 0.7% last week while SCHD gained 1.0% and VYM gained 1.1% — a rotation signal that shows up in the sector data too (Utilities +2.78%, Healthcare +2.10% versus Technology -0.63%). SCHD's 19.1% YTD return with an 18.2 P/E is the standout: it has captured most of the market's upside at a meaningfully lower multiple than the S&P 500's 25.2 or QQQ's 30.6. At the same time, JEPI at -1.0% YTD and GLD at -3.4% YTD show that "defensive" has not been a free lunch in 2026. BND at -5.2% YTD is the clearest argument for caution on duration: with the 10-year at 5.24% and the 30-year at 5.60%, total bond market exposure has been punished, and the ETF structure does not protect against that. A practical flow read is continued preference for dividend-tilted equity ETFs over long-duration fixed income. Expense ratios are 'n/a' in this feed, so cost comparisons should be verified before allocating.
5. How to Be Moving (Tactical Guidance)
Regime read. This is a low-volatility, high-rate, rotation regime. VIX at 14.84 (-4.4% weekly) says hedging demand is cheap and complacency is elevated; the S&P at 7,811.54 (+0.5%) and Dow at 51,654.95 (+0.8%) are grinding higher while the Nasdaq at 27,366.17 (-0.4%) stalls. The curve is positively sloped from 3 months (4.25%) through 30 years (5.60%), with the 10-year at 5.24%. That combination — calm volatility, positive-but-steep curve, long end at 5.6% — argues against paying up for duration and against paying up for unprofitable growth. Money is moving into Utilities, Healthcare, and Real Estate and out of Industrials, Technology, and Communication Services. Trade with that rotation, not against it.
Sectors to favor / avoid. Favor Utilities (+2.78%), Healthcare (+2.10%), Real Estate (+0.95%), and Basic Materials (+0.93%) — the rate-insensitive and hard-asset corners of the market. Selectively favor Energy (-0.19%) as a laggard with dividend support (XOM fwd P/E 14.7, CVX 14.4). Avoid or underweight Industrials (-0.88%), Technology (-0.63%), and Communication Services (-0.55%) as the momentum is currently flowing out of them — though note that Technology is the "avoid" where the best forward multiples now live (NVDA 14.4, AVGO 18.6), so this is a tactical underweight, not a strategic exit.
Cash: modestly raise. With 3-month T-bills at 4.25% and 6-month at 4.32%, cash is a real asset, not a drag. Against an S&P at 25.2x and a QQQ at 30.6x, holding a slightly elevated cash buffer is cheap optionality. Do not raise to extremes — the trend is still up and VIX at 14.84 does not signal an imminent break.
Bond duration: stay short. The curve rewards the front end and punishes the long end. BND at -5.2% YTD with a 10-year yielding 5.24% and a 30-year yielding 5.60% is a live demonstration of term-premium risk. Prefer 1–5 year maturities (year1 4.47%, year2 4.80%, year3 4.89%, year5 5.02%) over 20-year (5.65%) or 30-year (5.60%) exposure. For those who do want long bonds, the compensation is real but you are accepting mark-to-market pain if yields drift higher.
Action items for the week ahead:
- Rotate a slice of Technology/Industrials exposure toward Healthcare and Utilities, which led at +2.10% and +2.78% and are less sensitive to the 5.24% 10-year.
- For income, use the sell-off in MCD (-22.4% YTD, 3.1% yield, 19.1 P/E, 2.1 - Buy) and PEP (4.5% yield, 15.8 P/E) as scale-in candidates, but keep single-name size modest given the VZ-style yield traps in the bucket.
- Pair core equity exposure with SCHD (19.1% YTD, 18.2 P/E) rather than adding to QQQ (30.6 P/E) at current multiples.
- Keep bond duration in the 1–5 year part of the curve; avoid adding to long-end exposure with the 30-year at 5.60%.
- Note that JNJ reports 2026-10-13 (EPS est. 2.50) and is held in the dividend bucket — decide before the print whether that position is a trade or a hold.
- Watch the bank-heavy earnings slate on 2026-10-13 (JPM 5.93, GS 12.86, C 2.65, WFC 1.85) as the first real read on credit conditions in a 5%+ rate environment.
6. Upcoming Catalysts
| Date | Ticker | EPS Est | What to Watch |
|---|---|---|---|
| 2026-10-13 | C | 2.65 | Net interest income and credit-loss provisioning with the 10-year at 5.24% |
| 2026-10-13 | GS | 12.86 | Capital markets/trading revenue; investment banking pipeline |
| 2026-10-13 | JNJ | 2.50 | Healthcare earnings read-through; JNJ sits in the dividend bucket and is up 26.1% YTD |
| 2026-10-13 | JPM | 5.93 | The bellwether bank print — NII guidance and 2027 expense outlook |
| 2026-10-13 | UNH | 4.15 | Medical cost trend and utilization; healthcare sector is the second-best performer at +2.10% |
| 2026-10-13 | WFC | 1.85 | Deposit costs and loan growth under a 4.25%–4.32% short-rate backdrop |
| 2026-10-14 | BAC | 1.10 | Consumer credit quality and net interest margin |
| 2026-10-15 | TSM | 4.45 | AI/advanced-node demand — direct read-through to NVIDIA, Broadcom, AMD |
Economic events: data unavailable (not in current feeds).
7. Sources & Disclosures
News headlines used:
- Street Calls of the Week — Investing.com
- Exclusive-INWIT investors line up financing for possible take-private, sources say — Investing.com
- Musk vows affordable Starlink in India days before Ambani's record Jio IPO — Investing.com
- 8 emerging markets to consider in 2027: HSBC — Investing.com
- Foreign investors flee South Korean stocks as AI boom loses steam — Investing.com
- Justice Department probes TV networks over Trump pool boycott — Investing.com
- Russia stocks lower at close of trade; MOEX Russia Index unchanged — Investing.com
- Infosys sees no material impact from U.S. PERM suspension — Investing.com
- Should I put my nest egg in a 30-year Treasury bond? — MarketWatch
Data sources: Yahoo Finance, Financial Modeling Prep, U.S. Treasury.
Notes on data availability: Payout ratio, 5-year dividend growth, revenue growth, and ETF expense ratios are 'n/a' — not available in the current feed. Economic calendar, put-call ratios, and market breadth: data unavailable.
Disclaimer: For educational purposes only. Not investment advice. Do your own research before making any trades.
More from Financials